In collaboration with the Charité, Max Delbrück Center and the Deutsches Herzzentrum Berlin
Berlin, with the Charité – Universitätsmedizin Berlin, the Max Delbrück Center for Molecular Medicine (MDC) and the Deutsches Herzzentrum Berlin (DHZB) is one of seven locations of the German Center for Cardiovascular Research (DZHK). This was decided by an international panel of experts. The three partners will combine their cardiovascular and metabolic research in the DZHK under "Cardio Berlin". Associated partners are the German Institute for Nutrition Research in Potsdam-Rehbrücke (DIfE), as well as the Robert Koch Institute (RKI) in Berlin.
Charité and MDC with Cardio Berlin continue their successful cooperation begun in 1992. Also included for the first time is The Deutsche Herzzentrum. Prof. Walter Rosenthal, MDC's Scientific Director and Professor Annette Grüters-Kieslich, Dean of the Charité – Universitätsmedizin Berlin, and Prof. Roland Hetzer, Medical Director of the Deutsche Herzzentrum, welcomed the decision and saw it as a great success for the researchers and clinicians. "In basic and clinical research they are among the best in Germany. They attested "Only in close cooperation with the clinics, is it possible to implement the results of basic research into practice at the sickbed. “ The successful Berlin application was co-ordinated by Prof. Vera Regitz-Zagrosek, director of the Institute for Gender Research in Medicine at the Charité.
Cardio Berlin is based on prevention and will also explore gender differences in cardiovascular disease. To do this, clinicians and researchers of various disciplines work closely together, utilizing the most modern molecular genetic methods and imaging techniques, as well as holistic approaches (systems biology).
In addition to Berlin, the sites are Frankfurt, Göttingen, Greifswald, Hamburg/Kiel/Lübeck, Heidelberg/Mannheim and Munich. They were selected from more than 30 applicants. The DZHK like the other German centers of health research is financed, 90 percent by the federal government and 10 percent by the states.
The establishment of the DZHK and other health research centers dates back to a competition for the establishment of centers for German health research tendered by the Federal Ministry of Research in the spring of 2010. A major task of the German centers of health research should be to pool skills and thereby make a significant contribution to improving the prevention, diagnosis and treatment of common diseases.
The MDC is one of 17 institutions of the Hermann von Helmholtz Association of German Research Centers, the largest scientific organization in Germany. Under the umbrella of "molecular medicine", the MDC scientists explore not only heart circulation - and metabolic diseases, but also cancer and diseases of the nervous system. They want to understand the Formation of these complex illnesses in their origins - to understand the genes and their products, the proteins. Since its foundation in 1992 the MDC has worked closely together with clinicians, in particular with those of the Charité – Universitätsmedizin Berlin. The core of this cooperation is the MDC and the Charité on the Campus Berlin-Buch. Who since 2007 have jointly operated the "Experimental and Clinical Research Center (ECRC). This Clinical Research Center, has been built up according to US-American models of clinical research centers.
Links
For more information:
http://www.bmbf.de/
http://www.helmholtz.de/
http://www.dhzb.de/
http://rki.de/
http://www.dife.de/
Contact
Claudia Peter
Geschäftsbereich Unternehmenskommunikation
Charité – Universitätsmedizin Berlin
t.: +49 30 450 570 503
http://www.charite.de/
Barbara Bachtler
Pressestelle
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Berlin-Buch
Robert-Rössle-Straße 10
13125 Berlin
Tel.: +49 (0) 30 94 06 - 38 96
Fax: +49 (0) 30 94 06 - 38 33
http://www.mdc-berlin.de/
Back to Overview